Proteins

Product descriptionCU-CPT 4a (TLR3-IN-1) is a potent, highly selective TLR3 signaling inhibitor. CU-CPT 4a represses the expression of downstream signaling pathways mediated by the TLR3/dsRNA complex, including TNF-α and IL-1β .

Product descriptionCU-CPT 4a (TLR3-IN-1) is a potent, highly selective TLR3 signaling inhibitor. CU-CPT 4a represses the expression of downstream signaling pathways mediated by the TLR3/dsRNA complex, including TNF-α and IL-1β .

Product descriptionCU-CPT 4a (TLR3-IN-1) is a potent, highly selective TLR3 signaling inhibitor. CU-CPT 4a represses the expression of downstream signaling pathways mediated by the TLR3/dsRNA complex, including TNF-α and IL-1β .

Product descriptionCU-CPT 4a (TLR3-IN-1) is a potent, highly selective TLR3 signaling inhibitor. CU-CPT 4a represses the expression of downstream signaling pathways mediated by the TLR3/dsRNA complex, including TNF-α and IL-1β .

Product descriptionCU-CPT 4a (TLR3-IN-1) is a potent, highly selective TLR3 signaling inhibitor. CU-CPT 4a represses the expression of downstream signaling pathways mediated by the TLR3/dsRNA complex, including TNF-α and IL-1β .

General DescriptionCVF-NHS is generated by activating the complement system in normal human serum with cobra venom factor (CVF) purified from the venom of Naja naja kaouthia. CVF from Naja naja kaouthia produces an enzyme that cleaves both human C3

Potent and selective ALDH2 inhibitor.

Potent and selective ALDH2 inhibitor.

PKA signaling activator: promotes osteogenesis from hMSCs.

PKA signaling activator: promotes osteogenesis from hMSCs.

Competitive PTP1B inhibitor.

Competitive PTP1B inhibitor.